Lipids module 4: treatment of dyslipidaemia

Released 14 June 2024     Expires: 14 June 2026      Programme: Lipids 2 CPD/CME credits

Sponsorship Statement: Novartis Pharmaceuticals UK Ltd has provided OmniaMed Communications Ltd with an arm’s length sponsorship towards the update of the BJC e-learning programme in lipids.

Designed to give healthcare professionals an understanding of the diagnosis of dyslipidaemias and lipid profiling in cardiovascular risk assessment.

Module first published 9 July 2015
First revision 17 March 2021
Second revision June 2024

Learning objectives

Upon completing this module, participants should be better able to understand:

  • Evidence for lipid-lowering treatment
  • Which patients are eligible for lipid-lowering treatment
  • Use of lifestyle (diet and exercise) interventions
  • The lipid-lowering drug classes.


Module revised in 2024 by:
Dr Tina Mazaheri, Specialist Registrar in Chemical Pathology and Metabolic Medicine, Imperial College Healthcare NHS Trust, London
Dr Jaimini Cegla, Consultant in Chemical Pathology and Metabolic Medicine; and Lipids and Cardiovascular Risk Service, Department of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust
Programme editor: Dr Dermot Neely, Heart UK Trustee and Adviser

Module revised in 2021 by:
Dr Gavin Mercer-Smith, Specialist Registrar, Blood Sciences, Newcastle upon Tyne Hospitals NHS Foundation Trust
Programme editor: Dr Dermot Neely

Original module
Dr Dermot Neely
Dr David Thompson, Clinical Research Fellow, International Centre for Circulatory Health, Imperial College London, London
Dr Adie Viljoen, Honorary Consultant, Cambridge University Hospitals NHS Trust, Lister Hospital, Stevenage


2 CPD/CME credits, 2.0 hours
BJC Learning has assigned two hours of CPD/CME credit to this module

Endorsed by:

You need to login to take this module

You need to be a registered member to view this page. It's quick, free and offers you a host of other benefits, including the facility to print and download articles and supplements, access our archived issues and receive email updates when new issues and other content are online.


All rights reserved. No part of this programme may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publishers, Medinews (Cardiology) Limited.

It shall not, by way of trade or otherwise, be lent, re-sold, hired or otherwise circulated without the publisher’s prior consent.

Medical knowledge is constantly changing. As new information becomes available, changes in treatment, procedures, equipment and the use of drugs becomes necessary. The editors/authors/contributors and the publishers have taken care to ensure that the information given in this text is accurate and up to date. Readers are strongly advised to confirm that the information, especially with regard to drug usage, complies with the latest legislation and standards of practice.

Healthcare professionals should consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews (Cardiology) Limited cannot accept responsibility for any errors in prescribing which may occur.